Suppr超能文献

左心耳封堵术在解剖结构禁忌患者中的应用:来自 PINNACLE FLX 的研究结果。

Left atrial appendage closure in patients with prohibitive anatomy: Insights from PINNACLE FLX.

机构信息

Department of Medicine, Cardiovascular Division Vanderbilt University Medical Center, Nashville, Tennessee.

Department of Medicine, Cardiovascular Division Vanderbilt University Medical Center, Nashville, Tennessee.

出版信息

Heart Rhythm. 2021 Jul;18(7):1153-1161. doi: 10.1016/j.hrthm.2021.02.022. Epub 2021 May 3.

Abstract

BACKGROUND

Watchman 2.5 (Boston Scientific Inc, Marlborough, MA) implant success approaches 95% in registries, yet many patients are not attempted because of complex left atrial appendage (LAA) anatomy. Watchman FLX can expand the range of ostium width (14-31.5 mm) and depth available for LAA closure.

OBJECTIVE

The purpose of this study was to evaluate the safety and efficacy of Watchman FLX in patients with a failed Watchman 2.5 attempt or prohibitive LAA anatomy.

METHODS

The roll-in (n = 58) and primary effectiveness (n = 400) cohorts of the PINNACLE FLX trial comprised the study population. Subjects were identified who previously failed implantation of Watchman 2.5 (n = 11) or were not attempted because of prohibitive LAA anatomy (n = 88). Demographic characteristics, implant procedure details, and TEE follow-up data were compared to controls composed of enrollees not meeting these criteria (n = 359).

RESULTS

Watchman FLX LAA closure was successfully implanted in all subjects with a prior failed Watchman 2.5 attempt (n = 11 of 11). Subjects with previously failed Watchman 2.5 were more likely to receive a 35 mm FLX device than controls (27.3% vs 7.3%; P = .047). Patients with prohibitive anatomy had smaller LAA dimensions than did controls (diameter 18.0 ± 4 mm vs 20.4 ± 3 mm; P < .001 and length 23.7 ± 5 mm vs 28.9 ± 5 mm; P < .001). There was no difference in age, sex, CHADS-VASc score, HAS-BLED score, or primary efficacy between cohorts. Transesophageal echocardiography (TEE) at 12 months showed zero leak in 90.9% in the failed Watchman 2.5 cohort, 91.3% in the prohibitive anatomy cohort, and 89.5% in the control cohort (P = .84). Overall and cardiovascular mortality was lower in the prohibitive anatomy cohort (1.2% vs 8.8% in controls; P = .02).

CONCLUSION

Watchman FLX implantation in patients with a prior failed Watchman 2.5 attempt or prohibitive LAA anatomy remained safe and highly effective. The association of reduced overall mortality with smaller LAA dimension warrants future study.

摘要

背景

Watchman 2.5(波士顿科学公司,马萨诸塞州马尔伯勒)在注册研究中的植入成功率接近 95%,但由于左心耳(LAA)解剖结构复杂,许多患者未被尝试。Watchman FLX 可扩大 LAA 关闭可用的开口宽度(14-31.5 毫米)和深度。

目的

本研究旨在评估 Watchman FLX 在 Watchman 2.5 植入失败或 LAA 解剖结构禁忌的患者中的安全性和有效性。

方法

PINNACLE FLX 试验的滚动入组(n=58)和主要有效性(n=400)队列构成了研究人群。确定了先前植入 Watchman 2.5 失败(n=11)或由于 LAA 解剖结构禁忌而未尝试植入(n=88)的受试者。比较了这些符合这些标准的受试者(n=359)与对照组的人口统计学特征、植入程序细节和 TEE 随访数据。

结果

所有先前 Watchman 2.5 植入失败的患者(n=11 例中的 11 例)均成功植入 Watchman FLX LAA 封堵器。先前 Watchman 2.5 植入失败的患者比对照组更有可能接受 35 毫米 FLX 装置(27.3%对 7.3%;P=0.047)。具有禁忌解剖结构的患者的 LAA 尺寸小于对照组(直径 18.0±4 毫米对 20.4±3 毫米;P<.001 和长度 23.7±5 毫米对 28.9±5 毫米;P<.001)。两个队列在年龄、性别、CHADS-VASc 评分、HAS-BLED 评分或主要疗效方面无差异。12 个月时的经食管超声心动图(TEE)显示,在 Watchman 2.5 植入失败队列中,零漏诊率为 90.9%,在禁忌解剖结构队列中为 91.3%,在对照组中为 89.5%(P=0.84)。禁忌解剖结构队列的总体和心血管死亡率较低(8.8%对对照组中的 1.2%;P=0.02)。

结论

在先前 Watchman 2.5 植入失败或 LAA 解剖结构禁忌的患者中植入 Watchman FLX 仍然是安全且有效的。LAA 尺寸较小与总死亡率降低相关,值得进一步研究。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验